Authors:
Gautier-Charpentier, L
Ouedraogo-Traore, R
Simonon, A
Meda, N
Kpozehouen, A
Dahourou, H
Soudre, R
Van de Perre, P
Barin, F
Citation: L. Gautier-charpentier et al., Impact of human immunodeficiency virus type I subtype on HIV antibody detection in Burkina Faso, J ACQ IMM D, 28(2), 2001, pp. 194-195
Authors:
Lemiale, F
Brand, D
Lebigot, S
Verrier, T
Buzelay, L
Brunet, S
Barin, F
Citation: F. Lemiale et al., Immunogenicity of recombinant envelope glycoproteins derived from T-cell line-adapted isolates or primary HIV isolates - A comparative study using multivalent vaccine approaches, J ACQ IMM D, 26(5), 2001, pp. 413-422
Authors:
Plantier, JC
Damond, F
Souquieres, S
Brun-Vezinet, F
Simon, F
Barin, F
Citation: Jc. Plantier et al., V3 serological subtyping of human immunodeficiency virus type 2 infection is not relevant, J CLIN MICR, 39(10), 2001, pp. 3803-3807
Authors:
Lebigot, S
Roingeard, P
Thibault, G
Lemiale, F
Verrier, B
Barin, F
Brand, D
Citation: S. Lebigot et al., The transmembrane protein of HIV-1 primary isolates modulates cell surfaceexpression of their envelope glycoproteins, VIROLOGY, 290(1), 2001, pp. 136-142
Citation: F. Barin et al., The genetic diversity of viruses: consequences for blood screening and prevention of viral infection., TRANSF CL B, 7(5), 2000, pp. 472-478
Authors:
Hourioux, C
Brand, D
Sizaret, PY
Lemiale, F
Lebigot, S
Barin, F
Roingeard, P
Citation: C. Hourioux et al., Identification of the glycoprotein 41(TM) cytoplasmic tail domains of human immunodeficiency virus type 1 that interact with Pr55(Gag) particles, AIDS RES H, 16(12), 2000, pp. 1141-1147
Authors:
Brand, D
Lemiale, F
Thibault, G
Verrier, B
Lebigot, S
Roingeard, P
Buzelay, L
Brunet, S
Barin, F
Citation: D. Brand et al., Antigenic properties of recombinant envelope glycoproteins derived from T-cell-line-adapted isolates or primary human immunodeficiency virus isolatesand their relationship to immunogenicity, VIROLOGY, 271(2), 2000, pp. 350-362
Citation: I. Turbica et al., Antibodies to the CD4-binding site of HIV-1 gp120 in patients infected by variants belonging to the M or O group, J ACQ IMM D, 20(1), 1999, pp. 95-97
Authors:
Brengel-Pesce, K
Innocenti-Francillard, P
Morand, P
Michault, A
Poubeau, P
Barin, F
Saragosti, S
Seigneurin, JM
Citation: K. Brengel-pesce et al., Serologic and genetic characterization of HIV type 1 subtypes on Reunion Island, AIDS RES H, 15(9), 1999, pp. 787-792
Authors:
Candotti, D
Tareau, C
Barin, F
Joberty, C
Rosenheim, M
M'Pele, P
Huraux, JM
Agut, H
Citation: D. Candotti et al., Genetic subtyping and V3 serotyping of HIV type 1 isolates in Congo (vol 15, pg 309, 1999), AIDS RES H, 15(16), 1999, pp. 1491-1491
Authors:
Renjifo, B
Blackard, JT
Klaskala, W
Chaplin, BR
Shah, P
McLane, MF
Barin, F
Esparza, J
Zelaya, JE
Osmanov, S
Soto, R
Fernandez, JA
Baum, MK
Essex, ME
Citation: B. Renjifo et al., HIV-1 subtype B in Honduras, VIRUS RES, 60(2), 1999, pp. 191-197
Authors:
Meda, N
Gautier-Charpentier, L
Soudre, RB
Dahourou, H
Ouedraogo-Traore, R
Ouangre, A
Bambara, A
Kpozehouen, A
Sanou, H
Valea, D
Ky, F
Cartoux, M
Barin, F
Van de Perre, P
Citation: N. Meda et al., Serological diagnosis of human immunodeficiency virus in Burkina Faso: reliable, practical strategies using less expensive commercial test kits, B WHO, 77(9), 1999, pp. 731-739
Authors:
Kanki, PJ
Hamel, DJ
Sankale, JL
Hsieh, CC
Thior, I
Barin, F
Woodcock, SA
Gueye-Ndiaye, A
Zhang, E
Montano, M
Siby, T
Marlink, R
NDoye, I
Essex, ME
Citation: Pj. Kanki et al., Human immunodeficiency virus type 1 subtypes differ in disease progression, J INFEC DIS, 179(1), 1999, pp. 68-73